333. Simultaneous Disruption of Five SerpinA1 Genes in Mice Using CRISPR/Cas9 to Generate the First Animal Model of Alpha-1 Antitrypsin Deficiency

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33942-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Alpha-1-Antitrypsin Deficiency

2020English

Alpha-1 Antitrypsin Deficiency

Journal of insurance medicine (New York, N.Y.)
Medicine
2015English

Alpha‐1‐Antitrypsin Deficiency

English

Protein Modeling to Assess the Pathogenicity of Rare Variants of SERPINA1 in Patients Suspected of Having Alpha 1 Antitrypsin Deficiency

BMC Medical Genetics
Genetics
2019English

Diagnosing Alpha-1 Antitrypsin Deficiency: The First Step in Precision Medicine

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Engineering Plant Immunity: Using CRISPR/Cas9 to Generate Virus Resistance

Frontiers in Plant Science
Plant Science
2016English

Orphan Designation: Alpha-1 Antitrypsin (Inhalation Use), Treatment of Emphysema Secondary to Congenital Alpha-1-Antitrypsin Deficiency

Case Medical Research
2019English

The Prevalence of Alpha-1 Antitrypsin Deficiency in Ireland.

2009English

Using CRISPR-Cas9 to Generate Semi-Dwarf Rice Lines in Elite Landraces

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy